Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04465110
Other study ID # 109-1819-EXP
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2019
Est. completion date April 22, 2020

Study information

Verified date July 2020
Source California Baptist University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It was demonstrated that acute dietary supplementation with GSE reduced arterial blood pressure via reduction in Q in obese individuals. However, no studies have investigated the chronic effects of dietary GSE supplementation on hemodynamic responses during exercise. Given the fact that obesity is associated with an impaired function of eNOS, the effect of chronic dietary GSE supplementation on abnormal blood pressure response to exercise and aortic stiffness (AoS) needs be elucidated. Thus, it is hypothesized that GSE decreases systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), Q, and aortic stiffness at rest and during exercise. This study would determine that this supplementation may be used as a non-pharmacological intervention to prevent incident hypertension and cardiovascular events during exercise via enhanced endothelial function.


Description:

We investigated whether elevated blood pressure and aortic stiffness (AoS) characterized in obese and overweight males (N=10) are reduced following chronic GSE supplementation during exercise. Systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart rate (HR), stroke volume (SV), cardiac output (Q), total vascular conductance (TVC), and AoS to two submaximal cycling exercises (40% and 60% VO2peak) were compared 7 days after ingestion of GSE or placebo (PL) within an one week washout period. Compared with PL, GSE supplementation significantly decreased MAP at rest, 40%, and 60% workloads. AoS was significantly reduced at rest. Q tended to be decreased, but there was no significant difference. GSE had no effect on HR, TVC, and SV. Our study indicates that chronic supplementation with GSE reduces arterial pressure at rest and during exercise primarily via the combined reduction of AoS and Q. Thus, GSE can be a dietary supplement to treat augmented blood pressure responses in obese and overweight males at rest and during exercise.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date April 22, 2020
Est. primary completion date April 22, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 29 Years
Eligibility Inclusion Criteria:

- Overweight: 25-29.9 kg/m2

- Obese: > 30 kg/m2

- Waist circumference: > 90 cm

Exclusion Criteria:

- Antihypertensive medication

- Major systemic disease (cancer)

- Musculoskeletal diseases

- Cardiovascular diseases or symptoms including chest pain

- Myocardial infarction

- Arrhythmias

- Heart failure

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Grape Seed Extract
Subjects took a single dose of 600 mg GSE in capsule form through ingestion 2 hours prior to testing Dietary Supplement: Grape seed extract Two capsule grape seed extract (total 600 mg) per day

Locations

Country Name City State
United States California Baptist University Riverside California

Sponsors (1)

Lead Sponsor Collaborator
California Baptist University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary change in heart rate at rest and during exercise beats per minute 7 day supplementation
Primary change in stroke volume at rest and during exercise volume per stroke 7 day supplementation
Primary change in cardiac output at rest and during exercise total volume for one minute 7 day supplementation
Primary change in systolic blood pressure at rest and during exercise pressure exerted during contraction 7 day supplementation
Primary change in diastolic blood pressure at rest and during exercise pressure exerted during relaxation 7 day supplementation
Primary change in total vascular conductance at rest and during exercise one reported value (cardiac output/mean arterial pressure) 7 day supplementation
Primary change in aortic stiffness at rest Arbitrary unit 7 day supplementation
See also
  Status Clinical Trial Phase
Completed NCT04067323 - Improvement of Nutritional Status and Blood Lipid Profile by Using MCT Oil on Overweight and Obese Women N/A
Completed NCT04712227 - Can the Ratio of Chin-neck Circumference and Neck Circumference to Chin-neck Circumference Predict Difficult Intubation in Obese Patients?
Active, not recruiting NCT05946187 - Alternative Healthcare Delivery Strategies to Prevent Weight Regain After Bariatric Surgery N/A
Recruiting NCT05887271 - A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction Phase 2/Phase 3
Completed NCT04643899 - Effects of Electrostimulation on Glycemic Control in Obesity N/A
Completed NCT06357273 - The Effect of White Tea Consumption on Obesity
Active, not recruiting NCT06279780 - Gut Microbiota, Mitochondrial Function and Metabolic Health in Obesity N/A
Completed NCT04701138 - Bioavailability of SPMs in Obese Humans N/A
Completed NCT05790317 - Comparison of the Effect of Traditional Method and Eras Protocol in Obesity Surgery N/A
Completed NCT04740528 - Preference of Protein Intake and FTO rs1558902 Gene Polymorphism Among Women Obese